;PMID: 9464645
;source_file_2836.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:48..212] = [t:48..212]
;2)section:[e:216..254] = [t:216..254]
;3)section:[e:258..353] = [t:258..353]
;4)sentence:[e:357..896] = [t:357..896]
;5)sentence:[e:898..1082] = [t:898..1082]
;6)sentence:[e:1083..1266] = [t:1083..1266]
;7)section:[e:1270..1314] = [t:1270..1314]

;section 0 Span:0..42
;Neurosci Lett.  1997 Nov 28;238(1-2):21-4.
(SEC
  (FRAG (NNP:[0..8] Neurosci) (NNP:[9..13] Lett) (.:[13..14] .)
        (CD:[16..20] 1997) (NNP:[21..24] Nov) (CD:[25..27] 28) (::[27..28] ;)
        (CD:[28..31] 238) (-LRB-:[31..32] -LRB-) (NN:[32..35] 1-2)
        (-RRB-:[35..36] -RRB-) (::[36..37] :) (CD:[37..41] 21-4) (.:[41..42] .)))

;sentence 1 Span:48..212
;Effect of lipopolysaccharide on the gene expression of the enzymes involved
;in  tetrahydrobiopterin de novo biosynthesis in murine neuroblastoma cell
;line  N1E-115.
;[179..192]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP (NN:[48..54] Effect))
    (PP (IN:[55..57] of)
      (NP (NN:[58..76] lipopolysaccharide)))
    (PP (IN:[77..79] on)
      (NP
        (NP (DT:[80..83] the) (NN:[84..88] gene) (NN:[89..99] expression))
        (PP (IN:[100..102] of)
          (NP
            (NP (DT:[103..106] the) (NNS:[107..114] enzymes))
            (VP (VBN:[115..123] involved)
              (NP (-NONE-:[123..123] *))
              (PP-CLR (IN:[124..126] in)
                (NP
                  (NP (NN:[128..147] tetrahydrobiopterin)
                    (ADJP (FW:[148..150] de) (FW:[151..155] novo))
                    (NN:[156..168] biosynthesis))
                  (PP (IN:[169..171] in)
                    (NP
                      (NML (JJ:[172..178] murine) (NN:[179..192] neuroblastoma)
                           (NN:[193..197] cell) (NN:[198..202] line))
                      (NN:[204..211] N1E-115))))))))))
    (.:[211..212] .)))

;section 2 Span:216..254
;Mori K, Nakashima A, Nagatsu T, Ota A.
(SEC
  (FRAG (NNP:[216..220] Mori) (NNP:[221..222] K) (,:[222..223] ,)
        (NNP:[224..233] Nakashima) (NNP:[234..235] A) (,:[235..236] ,)
        (NNP:[237..244] Nagatsu) (NNP:[245..246] T) (,:[246..247] ,)
        (NNP:[248..251] Ota) (NNP:[252..253] A) (.:[253..254] .)))

;section 3 Span:258..353
;Department of Physiology, School of Medicine, Fujita Health University,
;Toyoake,  Aichi, Japan.
(SEC
  (FRAG (NNP:[258..268] Department) (IN:[269..271] of)
        (NNP:[272..282] Physiology) (,:[282..283] ,) (NNP:[284..290] School)
        (IN:[291..293] of) (NNP:[294..302] Medicine) (,:[302..303] ,)
        (NNP:[304..310] Fujita) (NNP:[311..317] Health)
        (NNP:[318..328] University) (,:[328..329] ,) (NNP:[330..337] Toyoake)
        (,:[337..338] ,) (NNP:[340..345] Aichi) (,:[345..346] ,)
        (NNP:[347..352] Japan) (.:[352..353] .)))

;sentence 4 Span:357..896
;The amounts of messenger RNA for three enzymes, namely guanosine triphosphate
; (GTP) cyclohydrolase 1,6-pyruvoyltetrahydropterin synthase, and sepiapterin 
;reductase, all of which are involved in the de novo biosynthesis of 
;(6R)-L-erythrodihydroxypropyl-2-amino-4-hydroxy-5,6,7,8-tetrahydro pteridine 
;(BH4) from GTP, were measured quantitatively in murine neuroblastoma cell
;line  N1E-115 by the competitive polymerase chain reaction (PCR) technique
;after  reverse transcription using a heterologous DNA fragment as an internal
;standard.
;[412..456]:gene-protein:"guanosine triphosphate  (GTP) cyclohydrolase"
;[457..494]:gene-protein:"1,6-pyruvoyltetrahydropterin synthase"
;[500..522]:gene-protein:"sepiapterin  reductase"
;[715..728]:malignancy-type:"neuroblastoma"
;[767..777]:gene-protein:"polymerase"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[357..360] The) (NNS:[361..368] amounts))
      (PP (IN:[369..371] of)
        (NP
          (NP (NN:[372..381] messenger) (NN:[382..385] RNA))
          (PP (IN:[386..389] for)
            (NP
              (NP (CD:[390..395] three) (NNS:[396..403] enzymes))
              (,:[403..404] ,)
              (NP
                (ADVP (RB:[405..411] namely))
                (NP
                  (NML
                    (NML (NN:[412..421] guanosine) (NN:[422..434] triphosphate))
                    (NML (-LRB-:[436..437] -LRB-) (NN:[437..440] GTP)
                         (-RRB-:[440..441] -RRB-)))
                  (NN:[442..456] cyclohydrolase))
                (NP (NN:[457..485] 1,6-pyruvoyltetrahydropterin)
                    (NN:[486..494] synthase))
                (,:[494..495] ,) (CC:[496..499] and)
                (NP (NN:[500..511] sepiapterin) (NN:[513..522] reductase))
                (,:[522..523] ,)
                (SBAR
                  (WHNP-1
                    (NP (DT:[524..527] all))
                    (WHPP (IN:[528..530] of)
                      (WHNP (WDT:[531..536] which))))
                  (S
                    (NP-SBJ-1 (-NONE-:[536..536] *T*))
                    (VP (VBP:[537..540] are)
                      (VP (VBN:[541..549] involved)
                        (NP-1 (-NONE-:[549..549] *))
                        (PP-CLR (IN:[550..552] in)
                          (NP
                            (NP (DT:[553..556] the)
                              (ADJP (FW:[557..559] de) (FW:[560..564] novo))
                              (NN:[565..577] biosynthesis))
                            (PP (IN:[578..580] of)
                              (NP
                                  (NN:[582..648] -LRB-6R-RRB--L-erythrodihydroxypropyl-2-amino-4-hydroxy-5,6,7,8-tetrahydro)
                                  (NN:[649..658] pteridine)
                                (PRN (-LRB-:[660..661] -LRB-)
                                  (NP (NN:[661..664] BH4))
                                  (-RRB-:[664..665] -RRB-))))
                            (PP (IN:[666..670] from)
                              (NP (NN:[671..674] GTP)))))))))))))))
    (,:[674..675] ,)
    (VP (VBD:[676..680] were)
      (VP (VBN:[681..689] measured)
        (NP-2 (-NONE-:[689..689] *))
        (ADVP (RB:[690..704] quantitatively))
        (PP-LOC (IN:[705..707] in)
          (NP
            (NML (JJ:[708..714] murine) (NN:[715..728] neuroblastoma)
                 (NN:[729..733] cell) (NN:[734..738] line))
            (NN:[740..747] N1E-115)))
        (PP-MNR (IN:[748..750] by)
          (NP (DT:[751..754] the) (JJ:[755..766] competitive)
            (NML
              (NML (NN:[767..777] polymerase) (NN:[778..783] chain)
                   (NN:[784..792] reaction))
              (NML (-LRB-:[793..794] -LRB-) (NN:[794..797] PCR)
                   (-RRB-:[797..798] -RRB-)))
            (NN:[799..808] technique)))
        (PP-TMP (IN:[809..814] after)
          (NP (JJ:[816..823] reverse) (NN:[824..837] transcription)))
        (S-MNR
          (NP-SBJ (-NONE-:[837..837] *))
          (VP (VBG:[838..843] using)
            (NP (DT:[844..845] a) (JJ:[846..858] heterologous)
                (NN:[859..862] DNA) (NN:[863..871] fragment))
            (PP (IN:[872..874] as)
              (NP (DT:[875..877] an) (JJ:[878..886] internal)
                  (NN:[887..895] standard)))))))
    (.:[895..896] .)))

;sentence 5 Span:898..1082
;Twenty-four hour activation of this cell line with 1 microg/ml 
;lipopolysaccharide resulted in statistically significant increases in the 
;amounts of the messages of all three enzymes.
;[1064..1081]:gene-protein:"all three enzymes"
(SENT
  (S
    (NP-SBJ
      (NP
        (NML (CD:[898..909] Twenty-four) (NN:[910..914] hour))
        (NN:[915..925] activation))
      (PP (IN:[926..928] of)
        (NP (DT:[929..933] this) (NN:[934..938] cell) (NN:[939..943] line)))
      (PP (IN:[944..948] with)
        (NP
          (NML
            (NML (CD:[949..950] 1) (NN:[951..957] microg))
            (PP (SYM:[957..958] /)
              (NP (NN:[958..960] ml))))
          (NN:[962..980] lipopolysaccharide))))
    (VP (VBD:[981..989] resulted)
      (PP-CLR (IN:[990..992] in)
        (NP
          (NP
            (ADJP (RB:[993..1006] statistically) (JJ:[1007..1018] significant))
            (NNS:[1019..1028] increases))
          (PP (IN:[1029..1031] in)
            (NP
              (NP (DT:[1032..1035] the) (NNS:[1037..1044] amounts))
              (PP (IN:[1045..1047] of)
                (NP
                  (NP (DT:[1048..1051] the) (NNS:[1052..1060] messages))
                  (PP (IN:[1061..1063] of)
                    (NP (DT:[1064..1067] all) (CD:[1068..1073] three)
                        (NNS:[1074..1081] enzymes))))))))))
    (.:[1081..1082] .)))

;sentence 6 Span:1083..1266
;Our data suggest that  lipopolysaccharide can activate the intrinsic pathway
;resulting in the enhanced  gene expression of these three enzymes in
;neuron-derived cells such as N1E-115.
;[1206..1225]:gene-protein:"these three enzymes"
(SENT
  (S
    (NP-SBJ (PRP$:[1083..1086] Our) (NNS:[1087..1091] data))
    (VP (VBP:[1092..1099] suggest)
      (SBAR (IN:[1100..1104] that)
        (S
          (NP-SBJ (NN:[1106..1124] lipopolysaccharide))
          (VP (MD:[1125..1128] can)
            (VP (VB:[1129..1137] activate)
              (NP
                (NP (DT:[1138..1141] the) (JJ:[1142..1151] intrinsic)
                    (NN:[1152..1159] pathway))
                (VP (VBG:[1160..1169] resulting)
                  (PP-CLR (IN:[1170..1172] in)
                    (NP
                      (NP (DT:[1173..1176] the) (VBN:[1177..1185] enhanced)
                          (NN:[1187..1191] gene) (NN:[1192..1202] expression))
                      (PP (IN:[1203..1205] of)
                        (NP (DT:[1206..1211] these) (CD:[1212..1217] three)
                            (NNS:[1218..1225] enzymes)))))
                  (PP-LOC (IN:[1226..1228] in)
                    (NP
                      (NP
                        (ADJP (NN:[1229..1235] neuron) (HYPH:[1235..1236] -)
                              (VBN:[1236..1243] derived))
                        (NNS:[1244..1249] cells))
                      (PP (JJ:[1250..1254] such) (IN:[1255..1257] as)
                        (NP (NN:[1258..1265] N1E-115))))))))))))
    (.:[1265..1266] .)))

;section 7 Span:1270..1314
;PMID: 9464645 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1270..1274] PMID) (::[1274..1275] :) (CD:[1276..1283] 9464645)
        (NN:[1284..1285] -LSB-) (NNP:[1285..1291] PubMed) (::[1292..1293] -)
        (NN:[1294..1301] indexed) (IN:[1302..1305] for)
        (NNP:[1306..1313] MEDLINE) (-RRB-:[1313..1314] -RSB-)))
